OnKure, Inc.
  • Home
    • Recent News
  • About
    • About Onkure
    • Team
    • Investors
  • Our Science
    • About Histone Deacetylases
    • Pipeline
  • News and Publications
    • Press Releases
    • Publications
  • Collaborations
  • Contact Us
  • Home
    • Recent News
  • About
    • About Onkure
    • Team
    • Investors
  • Our Science
    • About Histone Deacetylases
    • Pipeline
  • News and Publications
    • Press Releases
    • Publications
  • Collaborations
  • Contact Us

 

Press Releases September 21st, 2020Amelia Tanttila

Press Releases

September 21, 2020

OnKure and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Combination of OKI-179 and Binimetinib


September 24, 2019

OnKure Expands Executive Team and Appoints Head of Discovery, Chief Financial Officer and General Counsel


July 23, 2019

OnKure Executes License and Option Agreement with KDAc Therapeutics


June 11, 2019

OnKure and CU Cancer Center announce first patient enrolled in clinical trial of OKI-179


May 06, 2019

OnKure Announces FDA IND Regulatory Clearance to Start Phase 1 Trials for OKI-179


May 02, 2018

OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug


Press Releases September 21st, 2020Amelia Tanttila

© 2016 OnKure, Inc. All Rights Reserved.

Home

Main Page
Recent News

About OnKure

About Onkure
Team
Investors

Our Science

About Histone Deacetylases
Pipeline

News & Publications

Press Releases
Publications

Collaborations

Collaborators


OnKure, Inc.

1105 Spruce Street, Boulder, Colorado, 80302


© 2020 OnKure, Inc. All Rights Reserved.

— Current Footer — September 19th, 2020Amelia Tanttila